Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pleural Mesothelioma (MPM)”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Ended earlyNCT03175172
What this trial is testing

Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02611037
What this trial is testing

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaMesothelioma
H. Lee Moffitt Cancer Center and Research Institute 34
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Not applicableLooking for participantsNCT06886672
What this trial is testing

Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE VariaTionS

Who this might be right for
Mesothelioma, Malignant Pleural
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Not applicableStudy completedNCT05324436
What this trial is testing

Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 75
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Early research (Phase 1)Ended earlyNCT04836429
What this trial is testing

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Who this might be right for
Lung Non-Small Cell CarcinomaPleural Disorder
Roswell Park Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Large-scale testing (Phase 3)Ended earlyNCT04158141
What this trial is testing

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Epithelioid MesotheliomaStage I Pleural Malignant Mesothelioma AJCC v8+4 more
NRG Oncology 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT02153229
What this trial is testing

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Who this might be right for
Epitheliod Malignant Pleural Mesothelioma
Abramson Cancer Center at Penn Medicine 52
Early research (Phase 1)Study completedNCT02369198
What this trial is testing

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Asbestos Diseases Research Foundation 27
Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Large-scale testing (Phase 3)Study completedNCT02991482
What this trial is testing

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 144
Testing effectiveness (Phase 2)Study completedNCT01265433
What this trial is testing

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Who this might be right for
Malignant Pleural Mesothelioma
Sellas Life Sciences Group 41
Early research (Phase 1)Active Not RecruitingNCT04577326
What this trial is testing

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma (MPM)
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT00797719
What this trial is testing

Short Neoadjuvant Hemithoracic IMRT for MPM

Who this might be right for
Malignant Pleural Mesothelioma
University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT02863055
What this trial is testing

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 37
Testing effectiveness (Phase 2)Study completedNCT04480372
What this trial is testing

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Who this might be right for
Malignant Pleural MesotheliomaNon-small Cell Lung Cancer
Swiss Cancer Institute 68
Load More Results